Sep 21, 2022 | Access, Featured
By Surabhi Dangi-Garimella, Ph.D. Pharmaceutical research, manufacturing, and marketing are long, nuanced, and expensive processes. While innovation in this space has a direct impact on both disease, prevention and disease outcomes, patients may often feel distant...
Read more
Jun 6, 2022 | Access, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the power of precision medicine to harness genetic data to improve treatment regimens and overall outcomes for patients. However, they explain that accessing that data remains a challenge. They discuss the 2022...
Read more
Apr 9, 2022 | Access, Featured
On this episode of the podcast, Terry and Bob discuss the access and affordability challenges that patients with Alzheimer’s and diabetes face. They highlight a new analysis that concludes an enormous $350 billion of prescription drug rebates were spent last...
Read more
Apr 9, 2022 | Access, Featured
WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to CMS’ final decision to restrict access to FDA-approved Alzheimer’s treatments to clinical trial participants: “It’s a sad day for the millions...
Read more
Dec 30, 2021 | Access, Featured
In its second season, Patients Rising’s podcast has witnessed tremendous growth as we continue our coverage of topics that affect affordability and access to treatments and services, and dive into policy matters that regulate access and affordability. Here are a few...
Read more
